Mestag Therapeutics
PrivateLast Round
VC Round
Mar 17, 2026
Total Funding Raised
$46.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mestag Therapeutics is a biotechnology company that develops first-in-class immunotherapies targeting fibroblast-immune interactions to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mestag Therapeutics Comparables
Compare Mestag Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Macomics | 77% | |
| Agni Bio, Inc. | 77% | |
| F-star Therapeutics | 77% | |
Mestag Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 17, 2026 | ||||
| Grant | Aug 28, 2024 | ||||
| Seed | Aug 3, 2021 |
Key People
Founding team and executive leadership
Mestag Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | VC Round |
| SV Health Investors | VC Round, Seed |
| GV | VC Round, Seed |
| Forbion | VC Round, Seed |
| Northpond Ventures | VC Round, Seed |
| Johnson & Johnson Innovation - JJDC | VC Round |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
$40M raised in early funding.
- Aug 28, 2024
Secured $2M in grant funding from Innovate UK.
Mestag Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mestag Therapeutics's valuation, stock price, and market status.